Aspirin, Risk of Colorectal Cancer, & Genetic Risk-Letter

Cancer Prev Res (Phila). 2022 Oct 4;15(10):701-702. doi: 10.1158/1940-6207.CAPR-22-0209.

Authors

George Koulaouzidis¹, Dafni Charisopoulou^{2

3}, Wojciech Marlicz⁴

Affiliations

¹ Department of Biochemical Sciences, Pomeranian Medical University, Szczecin, Poland.
² Department of Pediatrics, Division of Pediatric Cardiology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, the Netherlands.
³ Academic Centre for Congenital Heart Disease, Nijmegen, the Netherlands.
⁴ Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland.

PMID: 36193657
DOI: 10.1158/1940-6207.CAPR-22-0209

No abstract available

Publication types

Comment

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal
Aspirin* / therapeutic use
Colorectal Neoplasms* / genetics
Colorectal Neoplasms* / prevention & control
Humans
Risk Factors

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin